News

Metastatic castration-resistant prostate cancer (mCRPC) treatment can involves chemotherapy, radiation, and more. Find the ...
It is well known that men are reluctant to see a doctor, especially a urologist. As a result, there is a risk that prostate ...
“This test could turn the tide on prostate cancer,” said Prof. Ros Eeles, who led the study. “We have shown that a relatively simple, inexpensive spit test to identify men of European heritage at ...
Uropathologists, for the first time, acknowledge issues with indolent Grade Group 1 tumors, which are leading to ...
Regular workouts are essential for a healthier, longer life, reducing the risk of major illnesses and early death.
The hope is the therapy can effectively target cancerous cells at relatively small doses while minimizing side effects.
Exercise improved erectile dysfunction compared with standard care among men with prostate cancer, according to study results ...
Use of NeuroSAFE during prostatectomy nearly doubled the number of patients who had no or mild erectile dysfunction ...
Cleveland Clinic Abu Dhabi, part of the M42 group, has achieved a historic milestone in global healthcare. In collaboration ...
The study advanced beyond a one-size-fits-all model by developing both a global XGBoost classifier and cancer-type-specific ...
At the core of AI’s value in cancer care is its performance in early detection and diagnostic support, where deep learning ...
The phase 2a LEGION-100 trial seeks to evaluate the safety and effectiveness of the SYNC-T/SV-102 combination therapy for treating metastatic castration-resistant prostate cancer (mCRPC) and to ...